American Society Of Health-System Pharmacists issued the following announcement on May 27.
The White House recently announced the launch of the first federally supported test-to-treat site, a part of its test-to-treat initiative designed to improve access to COVID-19 antiviral oral medications for certain high-risk patients.
In response, ASHP sent a letter to Ashish Jha, the White House COVID-19 Response Coordinator. The letter requests that the administration dramatically expand access to COVID-19 antivirals in all communities by removing the federal barrier preventing pharmacists from initiating therapy with these time-sensitive medications. More information: https://go.ashp.org/3lPG2Z7
Alerts Sign-up